They produce effects including: Decreased appetite Slower gastric emptying Increased insulin secretion Weight loss, including lean-mass reduction
Semaglutide, like Tirzepatide, was initially conceived as a treatment for type 2 diabetes
The current 4-week-per-dose-level schedule was specifically designed to minimize GI side effects while reaching therapeutic doses in a reasonable timeframe
These include diarrhea, nausea, abdominal discomfort, and metallic taste
In adults with obesity or overweight and knee osteoarthritis, retatrutide at 12 mg produced 23.7% body weight loss (an average of 60 pounds) compared to 4.6% with placebo over a full treatment period
If youre ready to harness the potential of Semaglutide (OZEMPIC/WEGOVY) in the realm of weight management, this read is for you